In HCC, mutations in NFE2L2, the gene that encodes Nrf2, are more common than in Keap1; these mutations occur as late events in HCC, as they were found in advanced stages of human liver carcinogenesis [84]. This evidence concerns the gene KEAP1 and hepatocellular carcinoma.